reported that miR-17/20a could reduce the expression of ITGB6 by attenuating the activation of TGFβ and phosphorylation of SMAD2/3 in esophageal squamous cell carcinoma (38). The gene discussed is ITGB6; the disease is esophageal squamous cell carcinoma.